Retroscreen Virology Limited, a global leader in anti-viral research, clinical trials and experimental challenge studies, is pleased to announce that the company will be represented at the World Influenza Congress Europe which will be held in Vienna, Austria between 6-8 December. This conference is an annual event which focuses specifically on Influenza vaccine development. Influenza continues to be the fastest growing segment in the adult vaccine market and is a key research area for Retroscreen, with Professor John Oxford (Retroscreen’s Scientific Director) being a recognised expert in the field. During the conference, Professor Oxford will be chairing the second day which will include presentations on novel Influenza vaccine research and clinical approaches. Retroscreen will also be represented by Dr Rob Lambkin-Williams, Chief Scientific Officer, and Mike Lawson, Business Development Manager.

For further information on the conference, please visit:
www.terrapinn.com/2011/flu